Jade Biosciences (JBIO) Treasury Shares (2022 - 2026)

Jade Biosciences (JBIO) has 5 years of Treasury Shares data on file, last reported at $307142.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $307142.0; the trailing twelve-month figure through Mar 2026 stood at $307142.0 (changed N/A YoY), and the FY2025 full-year result was $339473.0, down 34.38% from the prior year.
• Treasury Shares for Q1 2026 stood at $307142.0, down from $339473.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $28.9 million in Q4 2022 and bottomed at $1631.0 in Q2 2022.
• The 5-year median for Treasury Shares is $31881.0 (2023), against an average of $2.4 million.
• The widest annual swing landed in 2023, when Treasury Shares sank 99.92%; it then jumped 2254.76% in 2024.
• A 5-year view of Treasury Shares shows it stood at $28.9 million in 2022, then tumbled by 99.92% to $21968.0 in 2023, then surged by 2254.76% to $517293.0 in 2024, then tumbled by 34.38% to $339473.0 in 2025, then slipped by 9.52% to $307142.0 in 2026.
• The last three Treasury Shares figures came in at $307142.0 (Q1 2026), $339473.0 (Q4 2025), and $371804.0 (Q3 2025), per Business Quant data.

Peer Comparison